Identify More Accurate Predictive Models of Transplant Risk to Monitor and Evaluate New and Existing Patient Factors
Conditions
Brief summary
The objective is to provide a mechanism to store information regarding the demographic characteristics; pre-, intra-, and post-transplant laboratories; treatment strategies; complications; and outcomes in patients undergoing hepatic transplantation.
Detailed description
This study will be conducted at Methodist Dallas Medical Center and include data from hepatic transplant patients beginning in January 2019 and continuing until statistical significance is achieved. Patients will be identified based on ICD-10 procedure codes which are only available post-discharge in the EMR. Data will be collected once patient is discharged and no additional procedures are necessary. All cases meeting the inclusion criteria are expected to be included in this study
Interventions
OTHERObservational Transplant Analysis
Identify more accurate predictive models of transplant risk
Sponsors
Methodist Health System
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes
Inclusion criteria
* Age ≥18 years Submitted to hepatic transplantation (Current Procedural Terminology® code 47135
Exclusion criteria
* Does not meet inclusion criteria specified in 3.1
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Need for prospective registry studies to determine patient factors to measure long-term survivial | 2 years | As the demand for liver transplantation continues to grow, there is a need to identify more accurate predictive models of transplant risk. Therefore, prospective registry studies are needed to monitor and evaluate new and existing patient factors associated with long-term survival. |
| Methods of storing information on demographics of transplant patients | 2 yrs | The objective is to provide a mechanism to store information regarding the demographic characteristics; pre-transplant, intra-transplant, and post-transplant laboratories; treatment strategies; complications; and outcomes in patients undergoing hepatic transplantation. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Total Number and Description of Study Sites/Total Number of Subjects Projected | 2 yrs | This study will be conducted at Methodist Dallas Medical Center and include data from hepatic transplant patients beginning in January 2019 and continuing until statistical significance is achieved. Patients will be identified based on International classification of Disease (ICD-10) procedure codes which are only available post-discharge in the EMR. Data will be collected once patient is discharged and no additional procedures are necessary. All cases meeting the inclusion criteria are expected to be included in this study. |
Countries
United States
Contacts
Primary ContactColette N Ndjom, MS
Backup ContactLoretta W Bedell, MPH
Outcome results
None listed